• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].

作者信息

Chen Lin, Wei Xu-dong, Yin Qin-song

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.

PMID:22967387
Abstract
摘要

相似文献

1
[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].[CHAG与CAG预激方案治疗难治性及复发性急性髓系白血病的对比评估]
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.
2
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.在小剂量阿糖胞苷与阿柔比星联合粒细胞集落刺激因子（CAG方案）中增加阿柔比星剂量，作为复发/难治性混合表型急性白血病的挽救化疗是有效的。
Leuk Res. 2015 Aug;39(8):805-11. doi: 10.1016/j.leukres.2015.04.006. Epub 2015 Apr 20.
3
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.增加阿克拉霉素在小剂量阿糖胞苷与阿克拉霉素联合粒细胞集落刺激因子（CAG方案）中的剂量，可安全有效地治疗复发或难治性急性髓系白血病。
Int J Hematol. 2014;99(5):603-8. doi: 10.1007/s12185-014-1528-8. Epub 2014 Mar 13.
4
Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.克拉屈滨联合粒细胞集落刺激因子、阿糖胞苷和阿克拉霉素治疗难治/复发急性髓系白血病的 II 期多中心研究。
Oncologist. 2020 Nov;25(11):e1663-e1670. doi: 10.1634/theoncologist.2020-0818. Epub 2020 Sep 21.
5
Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.低剂量阿糖胞苷和阿克拉霉素联合粒细胞集落刺激因子（CAG 方案）与 Hyper-CVAD 方案在复发/难治性费城染色体阴性急性淋巴细胞白血病中的疗效比较。
Leuk Res. 2015 Mar;39(3):323-8. doi: 10.1016/j.leukres.2015.01.003. Epub 2015 Jan 16.
6
Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy.阿糖胞苷、阿克拉霉素和粒细胞集落刺激因子方案是治疗对首次诱导化疗耐药的急性髓细胞白血病患者的一种有效且安全的挽救方案。
Leuk Lymphoma. 2013 Nov;54(11):2452-7. doi: 10.3109/10428194.2013.776679. Epub 2013 Apr 2.
7
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.小剂量阿糖胞苷联合阿克拉霉素并联合粒细胞集落刺激因子预激（CAG方案）对老年急性髓系白血病患者预后的影响。
Leuk Res. 2007 Oct;31(10):1383-8. doi: 10.1016/j.leukres.2007.02.009. Epub 2007 Apr 8.
8
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia.对于复发/难治性急性髓系白血病，增加传统CAG（小剂量阿糖胞苷和阿柔比星联合粒细胞集落刺激因子）方案中阿柔比星的剂量作为挽救疗法比CAG方案更有效。
Leuk Res. 2015 Dec;39(12):1353-9. doi: 10.1016/j.leukres.2015.09.014. Epub 2015 Sep 18.
9
Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).低剂量阿糖胞苷和阿克拉霉素联合粒细胞集落刺激因子预激治疗伴有（8；21）易位的难治性或复发性急性髓系白血病患者的挽救性化疗。
Leuk Res. 2011 May;35(5):604-7. doi: 10.1016/j.leukres.2010.11.003. Epub 2010 Dec 3.
10
[Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in 50 patients with relapsed acute myeloid leukemia].低剂量阿糖胞苷与阿柔比星联合粒细胞集落刺激因子预激治疗50例复发急性髓系白血病
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):760-4.

引用本文的文献

1
[The clinical efficacy of the patients of acute myeloid leukemia with FLT3-ITD positive treated with sorafenib in combin ation with CHAG regimen].
Zhonghua Xue Ye Xue Za Zhi. 2016 May 14;37(5):419-21. doi: 10.3760/cma.j.issn.0253-2727.2016.05.013.